BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (Nasdaq: NRGN), a drug discovery and development company, announced today that William H. Koster, President and CEO, will present a Company overview at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Investor Conference on Thursday, April 12 at 10:20 a.m. ET.
